SubQ daily enables smaller, more frequent amounts with the ability to increase after the first week, depending on clinical direction
Sosne, G., Rimmer, D., Kleinman, H., & Ousler, G
Since the design and characterisation of these two compounds, other GLP-1/glucagon receptor co-agonists have been generated and the results from some clinical trials have been published
Life insurers can indeed adjust your premiums based on your height, weight and comorbidities
Systemic Side Effects Gastrointestinal Side Effects The most commonly reported side effects of GLP-1 RAs are gastrointestinal, including nausea, vomiting, diarrhea, constipation, abdominal pain, and dyspepsia [113,114,115]
The critical pattern to watch is escalation over weeks rather than an isolated flare after a large meal